HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alpha heavy chain disease alpha mRNA contain nucleotide sequences of unknown origins.

Abstract
Human alpha heavy chain disease is characterized by the production of abnormally short alpha IgH chains. In previously published cases it has been found that the malignant cells produce abnormal alpha mRNA, lacking VH and CH1 sequences and composed of a leader sequence peptide, sequences of variable length (69 to 84 bp) and of unknown origin, followed by normal CH2 and CH3 sequences. In this study we established the nucleotide sequence of alpha mRNA for six cases of alpha heavy chain disease. We observed that all six alpha mRNA lack the VH and CH1 sequences as do those previously described. They also contain in-frame inserts of unknown origin between the leader peptide and the normal CH2 and CH3 coding sequences. These inserts are of variable length (42 to 105 bp) and they are unrelated. These results suggest the existence of a common mechanism defect leading to deletions/insertions in alpha heavy chain disease rather than a specific interaction between alpha 1 IgH gene with a unique defined molecular species.
AuthorsF Fakhfakh, K Dellagi, H Ayadi, A Bouguerra, R Fourati, F Ben Ayed, J C Brouet, A Tsapis
JournalEuropean journal of immunology (Eur J Immunol) Vol. 22 Issue 11 Pg. 3037-40 (Nov 1992) ISSN: 0014-2980 [Print] Germany
PMID1425927 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulin Constant Regions
  • Immunoglobulin alpha-Chains
  • RNA, Messenger
  • DNA
Topics
  • Amino Acid Sequence
  • Base Sequence
  • Blotting, Northern
  • Blotting, Southern
  • DNA (chemistry)
  • Exons
  • Heavy Chain Disease (genetics)
  • Humans
  • Immunoglobulin Constant Regions (genetics)
  • Immunoglobulin alpha-Chains (genetics)
  • Molecular Sequence Data
  • RNA, Messenger (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: